Key result
Left ventricular hypertrophy in end-stage renal disease is an adaptive response to increased cardiac work driven by pressure overload, arterial stiffness, and elevated arterial inertance.
Answers are grounded in this paper and cite their sources.
Left ventricular hypertrophy in ESRD is a complex adaptive response driven by pressure overload, arterial stiffness, and vascular remodeling, serving as an independent risk factor for survival.
Left ventricular Hypertrophy is the most frequent alteration in ESRD and is an independent risk factor for survival. Left Ventricular Hypertrophy is an ‘adaptive’ response to increase in cardiac work that results in ESRD patients from increased stroke volume and high-output state (flow/volume overload, an increased opposition to left ventricular ejection (pressure overload), and an increased heart rate. Pressure overload is determined by peripheral resistance, arterial stiffness and elevated arterial inertance, while peripheral resistance is usually within the normal values. Increased arterial stiffness and inertance are associated with remodelling of large arteries which are dilated and hypertrophied. Arterial hypertrophy is accompanied by alterations of the intrinsic elastic properties of arterial walls that contribute to amplify the pressure load.
No takes yet. Share an insight, caveat, or question.
London et al. (1999) conducted a review in End-stage renal disease with left ventricular hypertrophy. Left ventricular hypertrophy in end-stage renal disease is an adaptive response to increased cardiac work driven by pressure overload, arterial stiffness, and elevated arterial inertance.
Synapse has enriched 10 related papers. Consider them for comparative context: